// App-Quantinova.ai

TCT-112 : Patient-oriented clinical outcomes and net adverse cardiovascular event in the Global Leaders trial

Researchers

Presenter

  • Patrick Serruys

Principal Investigators

  • Rodrigo Modolo

  • Norihiro Kogame

  • Kuniaki Takahashi

  • Chun-Chin Chang

  • Taku Asano

  • Yuki Katagiri

  • Mathias Vrolix

  • Krzysztof Zmudka

  • Carlo Tumscitz

  • Leonardo Bolognese

  • Ton Slagboom

  • Kurt Huber

  • Robert-Jan van Geuns

  • Pascal Vranckx

  • Marco Valgimigli

  • Stephan Windecker

  • Yoshinobu Onuma

Medical Centers

  • Ospedale San donato Arezzo, Italy, Florence, Arezzo, Italy

  • Ziekenhuis Oost Limburg, Genk, Belgium

  • Hartcentre Hasselt, Hasselt, Belgium

  • Wilheminen Hospital, Vienna, Austria

  • Imperial College, London, United Kingdom

  • Swiss Cardiovascular Center, Inselpsital, Bern, Switzerland

  • Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands

  • University Hospital of Bern, Bern, Switzerland

  • Dept Interventional Cardiology, John Paul II Hospital, Krakow, Poland

  • OLVG, Amsterdam, Netherlands

  • Academic Medical Center, Amsterdam, Netherlands

  • Radboudumc, Nijmegen, Netherlands

  • Taipei Veterans General Hospital, Taipei, TAIWAN

  • Thorax Center, Erasmus Medical Center, Rotterdam, Netherlands

  • Centro Cardiologico Universitario Ferrara, Ferrara, Ferrara, Italy

Locations

  • Italy

  • Belgium

  • United Kingdom

  • Netherlands

  • Poland

  • Taiwan

  • Austria

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Cardiovascular (CVS)

Disease

  • Stable coronary artery disease

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • Ticagrelor

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved